Altimmune COVID-19 Response

Click here to read about AdCOVID^TM Intranasal COVID-19 Vaccine and T-COVID^TM Intranasal Therapeutic for COVID-19 infection

Click here if you are interested in enrolling in our T-COVID EPIC Clinical Study

OUR PROGRAMS

Peptide-Based Therapeutics for Liver Diseases

Peptide-Conjugated Immunostimulants for Cancer

Intranasal Vaccines & Therapeutics for Anthrax, Influenza and COVID-19

OUR PIPELINE

Our diverse pipeline includes treatments for NASH (ALT-801), chronic Hepatitis B (HepTcell™), and conjugated immunostimulants for the treatment of cancer (ALT-702). In addition, we are developing intranasal vaccine & therapeutic candidates for anthrax, influenza and COVID-19.

LIVER THERAPIES

ALT-801

HepTcell™

CANCER

ALT-702

INTRANASAL VACCINES & THERAPEUTICS

NasoVAX™

NasoShield™

AdCOVID™

T-COVID™